Tabak, F. Et Al. 2021. SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY. HEPATOLOGY , vol.74 .

Tabak, F., Yoruk, G., Koksal, I., Erdem, H., Yildiz, D., Ince, N., ... YAMAZHAN, T.(2021). SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY. HEPATOLOGY , vol.74.

Tabak, Fehmi Et Al. "SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY," HEPATOLOGY , vol.74, 2021

Tabak, Fehmi Et Al. "SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY." HEPATOLOGY , vol.74, 2021

Tabak, F. Et Al. (2021) . "SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY." HEPATOLOGY , vol.74.

@article{article, author={Fehmi Tabak Et Al. }, title={SWITCHING TO TENOFOVIR ALAFENAMIDE IN HBV: NATIONWIDE REAL LIFE DATA OF EFFICACY AND SAFETY FROM TURKEY}, journal={HEPATOLOGY}, year=2021}